Rationale: About 1.1 billion people smoke tobacco globally and tobacco-related health care costs 1.8% of GDP in many countries. The majority of people are unable to quit smoking despite pharmacological intervention, highlighting the need to understand the pathophysiology associated with tobacco smoking to aid the development of new therapeutics. The reinforcing effects of tobacco smoking are thought to be mediated by the dopamine system. However, the nature of dopamine dysfunction seen in smokers is unclear.
Objective: To determine the nature and robustness of the evidence for dopaminergic alterations in smokers.
Methods: The entire MEDLINE, EMBASE, and PsycINFO databases were searched for studies from inception date to November 18, 2018. In vivo human molecular imaging studies of dopamine measures (dopamine synthesis or release capacity, transporter levels, receptor levels) in tobacco smokers were selected. Demographic, clinical, and imaging measures were extracted from each study and meta-analyses, and sensitivity analyses were conducted.
Results: Fourteen studies met inclusion criteria comprising a total sample of 219 tobacco smokers and 297 controls. The meta-analysis showed a significant reduction in dopamine transporter availability in the smokers relative to controls with an effect size of - 0.72 ([95% CI, - 1.38 to - 0.05], p = 0.03). However, there was no difference in D2/3 receptor availability in smokers relative to controls (d = -0.16 ([95% CI, - 0.42 to 0.1], p = 0.23). There were insufficient studies for meta-analysis of other measures. However, findings from the published studies indicated blunted dopamine release and lower D1 receptor availability, while findings for dopamine synthesis capacity were inconsistent.
Conclusion: Our data indicate that striatal dopamine transporter availability is lower but D2/3 receptors are unaltered in smokers relative to controls. We discuss the putative mechanisms underlying this and their implications.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591186 | PMC |
http://dx.doi.org/10.1007/s00213-019-05196-1 | DOI Listing |
BMJ Open
December 2024
Center for Environmental and Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan
Objectives: To examine the association between maternal plasma cotinine concentrations during pregnancy and attention-deficit/hyperactivity disorder (ADHD) related characteristics in children.
Design: Prospective birth cohort study from the Hokkaido Study on Environment and Children's Health.
Setting: Hokkaido, Japan.
BMJ Open
December 2024
Department of Community Health Nursing, Member of Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
Objectives: In recent years, non-invasive stimulation technologies such as repetitive transcranial magnetic stimulation, transcranial direct current stimulation, bioresonance and auriculotherapy have been used for smoking cessation. Individuals may face various challenges throughout the quitting process. This study aimed to explore the challenges of smoking cessation for users of non-invasive stimulation technologies in Iran.
View Article and Find Full Text PDFBMJ Open
December 2024
Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Introduction: Tobacco smoking remains a leading cause of ill-health, premature mortality and a driver of health inequalities. To support smokers in England, a comprehensive approach to treating tobacco dependence is being implemented. This includes offering support to all people admitted to hospitals, as well as women and pregnant people within NHS settings.
View Article and Find Full Text PDFJ Vasc Surg
December 2024
Department of Vascular Surgery, Red Cross Hospital, Athens, Greece.
Objective: The purpose of this study is to identify variables at the time of clinical presentation which place patients at higher risk for mortality following carotid endarterectomy (CEA) for symptomatic lesions. Further, this study will create a risk score for mortality within two years following CEA for symptomatic stenosis to help tailor future postoperative and long-term management by identifying patients who require heightened vigilance in postoperative care to facilitate survival.
Methods: The Vascular Quality Initiative (VQI) CEA module was queried for procedures performed for symptomatic (within 180 days) carotid bifurcation stenosis.
J Subst Use Addict Treat
December 2024
Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Tobacco Control Division, Health Promotion Administration, Ministry of Health and Welfare, Taipei, Taiwan; Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan; Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan. Electronic address:
Introduction: Although the relationships between personal factors and smoking abstinence are well-documented, institutional variation in smoking abstinence remains underexplored. This study investigates institutional variation in the six-month smoking abstinence prevalence among institutions participating in Taiwan's Second-Generation Tobacco Cessation Program (SGTCP) and examines institutional characteristics associated with smoking cessation success.
Methods: The analysis included 304,757 pharmacotherapy and health education sessions from 160,336 participants who received smoking cessation services across 2420 institutions under the SGTCP between 2000 and June 2022.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!